Bank of America’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Buy |
|
|||||
|
2025
Q1 | $85.8K | Sell |
|
|||||
|
2024
Q4 | $193K | Sell |
|
|||||
|
2024
Q3 | $284K | Buy |
|
|||||
|
2024
Q2 | $226K | Buy |
|
|||||
|
2024
Q1 | $39.5K | Sell |
|
|||||
|
2023
Q4 | $90.6K | Sell |
|
|||||
|
2023
Q3 | $147K | Buy |
|
|||||
|
2023
Q2 | $103K | Sell |
|
|||||
|
2023
Q1 | $181K | Buy |
|
|||||
|
2022
Q4 | $446K | Sell |
|
|||||
|
2022
Q3 | $1.2M | Buy |
|
|||||
|
2022
Q2 | $1.23M | Buy |
|
|||||
|
2022
Q1 | $346K | Sell |
|
|||||
|
2021
Q4 | $1.66M | Sell |
|
|||||
|
2021
Q3 | $3.13M | Buy |
|
|||||
|
2021
Q2 | $2.25M | Buy |
|
|||||
|
2021
Q1 | $2.25M | Buy |
|
|||||
|
2020
Q4 | $1.79M | Sell |
|
|||||
|
2020
Q3 | $1.87M | Sell |
|
|||||
|
2020
Q2 | $3.51M | Sell |
|
|||||
|
2020
Q1 | $3.37M | Buy |
|
|||||
|
2019
Q4 | $3.66M | Sell |
|
|||||
|
2019
Q3 | $5.91M | Buy |
|
|||||
|
2019
Q2 | $11.1M | Buy |
|
|||||
|
2019
Q1 | $6.65M | Buy |
|
|||||
|
2018
Q4 | $5.64M | Sell |
|
|||||
|
2018
Q3 | $11.8M | Sell |
|
|||||
|
2018
Q2 | $13.6M | Sell |
|
|||||
|
2018
Q1 | $107M | Buy |
|
|||||
|
2017
Q4 | $22.9M | Sell |
|
|||||
|
2017
Q3 | $13.1M | Buy |
|
|||||
|
2017
Q2 | $7.89M | Buy |
|
|||||
|
2017
Q1 | $6.49M | Buy |
|
|||||
|
2016
Q4 | $1.7M | Buy |
|
|||||
|
2016
Q3 | $382K | Sell |
|
|||||
|
2016
Q2 | $350K | Buy |
|
|||||
|
2016
Q1 | $161K | Sell |
|
|||||
|
2015
Q4 | $1.26M | Buy |
|
|||||
|
2015
Q3 | $426K | Sell |
|
|||||
|
2015
Q2 | $1.8M | Buy |
|
|||||
|
2015
Q1 | $80K | Buy |
|
|||||
|
2014
Q4 | $110K | Sell |
|
|||||
|
2014
Q3 | $380K | Buy |
|
|||||
|
2014
Q2 | $92K | Sell |
|
|||||
|
2014
Q1 | $219K | Sell |
|
|||||
|
2013
Q4 | $372K | Buy |
|
|||||
|
2013
Q3 | $329K | Sell |
|
|||||
|
2013
Q2 | $726K | Buy |
|